Rockefeller Financial Services’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $121K | Sell |
2,599
-398,027
| -99% | -$18.5M | ﹤0.01% | 371 |
|
|
2017
Q3 | $21.3M | Sell |
400,626
-7,753
| -2% | -$413K | 0.41% | 61 |
|
|
2017
Q2 | $25.4M | Buy |
408,379
+33,716
| +9% | +$2.09M | 0.5% | 55 |
|
|
2017
Q1 | $25.4M | Sell |
374,663
-5,098
| -1% | -$346K | 0.51% | 50 |
|
|
2016
Q4 | $26.7M | Buy |
379,761
+7,210
| +2% | +$507K | 0.54% | 46 |
|
|
2016
Q3 | $26.4M | Sell |
372,551
-23,795
| -6% | -$1.69M | 0.55% | 47 |
|
|
2016
Q2 | $19.4M | Sell |
396,346
-6,962
| -2% | -$341K | 0.39% | 52 |
|
|
2016
Q1 | $25.5M | Buy |
403,308
+113,401
| +39% | +$7.18M | 0.5% | 48 |
|
|
2015
Q4 | $32.5M | Buy |
289,907
+83,741
| +41% | +$9.39M | 0.63% | 47 |
|
|
2015
Q3 | $19.9M | Buy |
206,166
+195,335
| +1,803% | +$18.8M | 0.4% | 56 |
|
|
2015
Q2 | $1.11M | Hold |
10,831
| – | – | 0.02% | 186 |
|
|
2015
Q1 | $672K | Sell |
10,831
-498
| -4% | -$30.9K | 0.01% | 220 |
|
|
2014
Q4 | $497K | Sell |
11,329
-1,040
| -8% | -$45.6K | 0.01% | 240 |
|
|
2014
Q3 | $700K | Sell |
12,369
-13,682
| -53% | -$774K | 0.02% | 230 |
|
|
2014
Q2 | $1.17M | Buy |
26,051
+14,380
| +123% | +$645K | 0.03% | 211 |
|
|
2014
Q1 | $571K | Buy |
+11,671
| New | +$571K | 0.01% | 247 |
|